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Background
The radiolabelled inhibitor of the multidrug efflux transporter P-glycoprotein (P-gp) [
11 C]elacridar was developed as a positron emission tomography (PET) tracer to assess expression levels of P-gp at the blood-brain barrier (BBB) [1] . [ 11 C]Elacridar was shown to interact specifically with P-gp at the rodent BBB, but its brain PET signal was very low, which was possibly caused by transport of [ 11 C]elacridar by P-gp [1] . In an attempt to gain a better understanding of the required properties of an effective P-gp PET tracer we evaluated 11 C-labelled MC113, a structural analogue of elacridar, which was characterised as an unambiguous non-transported P-gp inhibitor and which possesses lower molecular weight, lower lipophilicity and higher potency for P-gp inhibition than elacridar (EC 50 for inhibition of [ 3 H]vinblastine transport in Caco-2 cell monolayers: 0.6 µM vs. 2.0 µM for elacridar) [2] .
Methods
Female wild-type (n = 3) and Mdr1a/b −/− (n = 2) mice (Taconic Inc., USA) underwent paired PET scans with [ 11 C]MC113 using a microPET Focus220 scanner (Siemens, Medical Solutions, USA). A baseline scan (150 min), during which the P-gp inhibitor tariquidar (15 mg/kg) was administered i.v. at 60 min after radiotracer injection, was followed by a second 60-min scan at 2 h after administration of tariquidar. Whole-brain time-activity curves were calculated using the image analysis software Amide.
Results
[ 11 C]MC113 was evaluated using an identical set-up which we had previously used for [ 11 C]elacridar and which employed a combination of chemical and genetic knockout of P-gp [1] . [ 11 C]MC113 had a 3 times higher peak brain activity uptake than [
11 C]elacridar, but otherwise behaved identically to [
11 C]elacridar, in that brain activity uptake was higher in Mdr1a/b −/− than in wildtype mice and that inhibitor administration increased brain activity uptake in wild-type mice. However, the observed effects were smaller for [ 
Conclusions
Our data suggest that [
11 C]MC113 interacts with P-gp at the murine blood-brain barrier, but as for [
11 C]elacridar its in vivo behaviour points to transport by P-gp. The higher brain activity uptake of [ 11 C]MC113 might be an advantage over [ 11 C]elacridar for PET imaging of P-gp.
